<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045200"><TermName>fludarabine</TermName><TermPronunciation>(floo-DAR-uh-been)</TermPronunciation><TermDefinition><DefinitionText>The active ingredient in a drug used to treat B-cell chronic lymphocytic leukemia (CLL) that has not responded to treatment with other anticancer drugs or that has gotten worse. Fludarabine blocks cells from making DNA and may kill cancer cells. It is a type of purine antagonist and a type of ribonucleotide reductase inhibitor.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000705142" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;fludarabine&quot;" language="en" id="_3"/><MediaLink ref="CDR0000705143" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;fludarabina&quot;" language="es" id="_4"/><SpanishTermName>fludarabina</SpanishTermName><SpanishTermDefinition><DefinitionText>Principio activo de un medicamento que se usa para tratar la leucemia linfocítica crónica (LLC) de células B que no ha respondido al tratamiento con otros medicamentos contra el cáncer o ha empeorado. La fludarabina impide que las células elaboren ADN y puede destruir las células cancerosas. Es un tipo de antagonista de la purina y un tipo de inhibidor de la ribonucleótido reductasa.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2008-08-25</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000597019">Fludarabine Phosphate</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
